UNII B22547B95K

TRISODIUM CITRATE DIHYDRATE

Unique Ingredient Identifier B22547B95K is listed as a ingredient substance
UniiB22547B95K
Preferred Substance NameTRISODIUM CITRATE DIHYDRATE
Rn6132-04-3
NcitC66642
Rxcui221163
Pubchem71474
Molecular FormulaC6H5O7.3Na.2H2O
InchikeyNLJMYIDDQXHKNR-UHFFFAOYSA-K
SmilesO.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
Unii TypeINGREDIENT SUBSTANCE
RN6132-04-3
NCITC66642
RXCUI221163
PUBCHEM71474
MFC6H5O7.3Na.2H2O
INCHI KEYNLJMYIDDQXHKNR-UHFFFAOYSA-K
SMILESO.O.[Na+].[Na+].[Na+].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O

Alternate Names

Dosage Forms

UNII B22547B95K TRISODIUM CITRATE DIHYDRATE is commonly included in medications in the following forms.

RouteDosage FormPotency
IM - IVINJECTABLE0.025 %
IM - IVINJECTION24.75 MG/1ML
IM - IVINJECTION2.5 %
IM - IVSOLUTION0.025 %
IM - IV - SCINJECTION0.21 %
IM - IV - SCSOLUTION, INJECTION2.3 MG/1ML
IM - SCINJECTION0.2 %
INHALATIONSOLUTION6.2 mg/3 mL
INHALATIONSOLUTION0.86 MG/INH
INHALATIONSOLUTION0.5 MG/ML
INHALATIONSUSPENSION, FOR INHALATION0.005 %
INTRA-ARTICULARINJECTION, SOLUTION11 mg/1mL
INTRACARDIACINJECTION10.35 mg/5mL
INTRAMUSCULARINJECTABLE8.1 mg/1mL
INTRAMUSCULARINJECTABLE8 %
INTRAMUSCULARINJECTION25.8 mg/1mL
INTRAMUSCULARINJECTION2.88 %
INTRAMUSCULARINJECTION, SOLUTION24.75 mg/1mL
INTRAMUSCULARINJECTION, SOLUTION0.025 %W/V
INTRAMUSCULARSOLUTION, INJECTION2.5 %W/V
INTRAOCULARINJECTION, SOLUTION, CONCENTRATE0.55 %
INTRAVENOUSINJECTABLE8 %
INTRAVENOUSINJECTABLE3.7 MG/1ML
INTRAVENOUSINJECTION25.8 mg/1mL
INTRAVENOUSINJECTION2.88 %
INTRAVENOUSINJECTION, SOLUTION24.75 mg/1mL
INTRAVENOUSINJECTION, SOLUTION0.16 %
INTRAVENOUSLIQUID0.36 %
INTRAVENOUSPOWDER2.4 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED23.52 %
INTRAVENOUSSOLUTION0.37 %
INTRAVENOUSSOLUTION, INJECTION2.5 %
INTRAVENOUS INFUSIONINJECTION4 mg/1mL
INTRAVENOUS INFUSIONINJECTION0.03 %
INTRAVITREALSUSPENSION, INJECTION0.17 %
IRRIGATIONINJECTION, SOLUTION, CONCENTRATE0.55 %
IV(INFUSION)INJECTABLE0.48 %
IV(INFUSION)INJECTION0.48 %
IV(INFUSION)INJECTION0.24 mg/1mL
IV(INFUSION)SOLUTION, INJECTION3.04 %
NASALSPRAY1.44 %
NASALSPRAY, METERED680 MG/INH
NASALSPRAY, METERED0.28 %
OPHTHALMICSOLUTION4.47 MG/1ML
OPHTHALMICSOLUTION0.3 %
OPHTHALMICSOLUTION, DROPS2.94 mg/1mL
OPHTHALMICSOLUTION, DROPS0.45 %
ORALPOWDER, FOR SUSPENSION1100 MG/140ML
ORALSOLUTION28 MG/5ML
ORALSOLUTION15.75 MG/1ML
ORALSOLUTION3.75 mg/15 mL
ORALSOLUTION, ELIXIR1.5 MG/5ML
ORALSOLUTION, ELIXIR0.047 %W/V
ORALSOLUTION, FOR INHALATION1 MG/.5ML
ORALSOLUTION, LIQUID3.3 MG/1ML
ORALSOLUTION, SYRUP59 MG/5ML
ORALSUSPENSION90 MG/5ML
ORALSUSPENSION0.04 mg/1mL
ORALSUSPENSION, FOR INHALATION1 MG/2ML
ORALSUSPENSION, LIQUID2.13 MG/1ML
ORALSYRUP55.24 MG/5ML
ORALSYRUP0.95 %W/W
ORALTABLET110 MG
ORALTABLET, EXTENDED RELEASE101 MG
PARENTERALINJECTION0.48 %
RESPIRATORY (INHALATION)INHALANT0.2 %
RESPIRATORY (INHALATION)SOLUTION, FOR INHALATION1.83 %
RESPIRATORY (INHALATION)SUSPENSION, FOR INHALATION0.1 %
SUBCUTANEOUSINJECTION10.35 mg/5mL
SUBCUTANEOUSINJECTION0.2 %
SUBCUTANEOUSINJECTION, SOLUTION0.2 %
SUBLINGUALFILM3.62 mg
SUBLINGUALTABLET17 MG
TOPICALCLOTH0.06 %W/W
TOPICALCREAM0.08 %W/W
TOPICALEMULSION, CREAM0.1 %W/W
TOPICALGEL0.14 %W/W
TOPICALLOTION0.32 %W/W
TOPICALOPHTHALMIC SUSPENSION DOSAGE FORM0.5 %W/V
TOPICALSHAMPOO2.67 %W/V
TOPICALSOLUTION4.47 MG/1ML
TOPICALSOLUTION0.3 %W/W

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.